Article
BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel.
The British journal of dermatology - 1 Apr 2013
Gonzalez D, Fearfield L, Nathan P, Tanière P, Wallace A, Brown E, Harwood C, Marsden J, Whittaker S
Abstract excerpt
The incidence of melanoma has increased rapidly over the past 30 years, and the disease is now the sixth most common cancer among men and women in the U.K. Many patients are diagnosed with or develop metastatic disease, and survival is substantially reduced in these patients. Mutations in the BRAF gene have been identified as key drivers of melanoma cells and are found in around 50% of cutaneous melanomas....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.